Appendix G Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes

Similar documents
RENINE Annual Report 2015

ESRD Dialysis Prevalence - One Year Statistics

RENINE year report 2016

Chapter 15: Causes of Death on Renal Replacement Therapy

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

Chapter 1. Incidence of End Stage Kidney Disease. Contents:

Chapter 8: ESRD Among Children, Adolescents, and Young Adults

ERA-EDTA Registry Annual Report 2001

USRDS UNITED STATES RENAL DATA SYSTEM

CHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston

2014 /2018 ERA-EDTA PRD Code ERA-EDTA PRD code 1996 ERA-EDTA. SNOMED CT concept identifier Convert ERA-EDTA Primary Renal Diagnosis (PRD) Term

Chapter 15: Report of the Paediatric Renal Registry 1999

Chapter 7: ESRD among Children, Adolescents, and Young Adults

ERA-EDTA ERA-EDTA Primary Renal Diagnosis (PRD) Term ERA-EDTA PRD classification SNOMED CT PRD Code 1/1/2015

RaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable

RaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable

Glomerular pathology in systemic disease

CHRONIC KIDNEY DISEASE (CKD)

SPECIALISED SERVICES NATIONAL DEFINITIONS SET (THIRD EDITION 2008) Specialised Renal Services (adult) - Definition No. 11

Kidney Transplant. Description

DIABETES MELLITUS. Kidney in systemic diseases. Slower the progression: Pathology: Patients with diabetes mellitus are prone to other renal diseases:

NAPRTCS Annual Transplant Report

NAPRTCS Annual Transplant Report

Chapter IX. Pediatric End Stage Renal Disease. Incidence of Reported Pediatric ESRD

SCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND 2015

Histopathology: Glomerulonephritis and other renal pathology

Protocol. Kidney Transplant

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES OMB No

Final Report: Update on Prior Living Donors Who Were Subsequently Placed on the Waiting List

New perspec)ves on withdrawal from dialysis. Jennifer Chan, Phil Clayton, Stephen McDonald, John Agar, Ma?hew Jose

A clinical syndrome, composed mainly of:

Dr Ian Roberts Oxford

Renal Disease. Please refer to the assignment page Three online modules TBLs

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Epidemiology of CKD in Children

Dialysis Mortality Regional Clinical Audit Report 2011

RaDaR Inclusion and Exclusion Criteria

Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Chapter IV. Incidence and Causes of Treated ESRD. Methods

North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2005 Annual Report. Renal Transplantation. Chronic Renal Insufficiency

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST

Index. electron microscopy, 81 immunofluorescence microscopy, 80 light microscopy, 80 Amyloidosis clinical setting, 185 etiology/pathogenesis,

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT

The new ERA-EDTA PRDs UK Renal SNOMED CT subset TheProject

Nephrology Dialysis Transplantation

Protocol: CRI Registry (CRIPR) Targeted Adverse Event(ADV)

Kidney Transplant. Policy Number: Last Review: 8/2014 Origination: 8/2001 Next Review: 8/2015

Analgesic and NSAID-induced Kidney Disease

PATTERNS OF RENAL INJURY

NAPRTCS Annual Report

Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.

Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome.

NAPRTCS Annual Report

CHAPTER 3 SECONDARY GLOMERULONEPHRITIS

Kidney Transplantation

1. Normal and pathological embryology of the urinary and genital tract 2. Nephrology 3. Infection

THIS chapter presents basic information about

Clinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review

NAPRTCS Annual Report

University of Bristol - Explore Bristol Research

2015 Children's Mercy Hospitals and Clinics. All Rights Reserved.

FOLLOW-UP AFTER EMERGENCY DEPARTMENT VISIT FOR PEOPLE WITH HIGH-RISK MULTIPLE CHRONIC CONDITIONS (FMC) HEDIS (Administrative)

Paediatric Nephrology

CHAPTER 2. Primary Glomerulonephritis

Appendix C: Renal Services Described for Non-physicians

S2 File. Clinical Classifications Software (CCS). The CCS is a

3/5/18. Background. Registry Reports. Dialysis Registry Update and Future Directions

Biopsy-Proven Childhood Glomerulonephritis in Johor

Proposed Scope of Work for KDIGO Clinical Practice Guideline for the Evaluation and Management of Candidates for Kidney Transplantation

Mr PA. Clinical assessment of hydration. Poor urine output Sunken eyes Moistness of mucosa Cool peripheries Reduction in weight Postural hypotension

Kidney Disorders. Renal cysts. Policystic Kidney Diseases. Cystic Renal Dysplasia. Autosomal-Dominant (Adult) Polycystic

CHAPTER 4. Paediatric Renal Biopsies

Year 2004 Paper one: Questions supplied by Megan

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

CHAPTER 3. Secondary Glomerulonephritis

BETA-2 MICROGLOBULIN Test Code Test Name CPT

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS

Glomerular diseases mostly presenting with Nephritic syndrome

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Secondary IgA Nephropathy & HSP

Targeted Adverse Event (ADV)

Case Presentation Turki Al-Hussain, MD

COMPLETION DATE - 31-MAR-2011

Atlas of the Vasculitic Syndromes

Policy Specific Section:

InterQual Level of Care 2018 Index

Diseases of the Kidney. Janos Vasko

COMPREHENSIVE DIABETES CARE

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES OMB No

International IBD Genetics Consortium

GLOMERULAR TUBULAR/INTERSTITIAL BLOOD VESSELS

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

TNU QUIZ. Affiliation: 1. Presence of the following may indicate non-diabetic kidney disease in a patient with type 2 diabetes mellitus:

AN APPROACH TO HEMATURIA. Dr Saima Ali

Contractor Information. LCD Information. Local Coverage Determination (LCD): Retroperitoneal Ultrasound (L34577) Document Information

Protocol: 1st Dialysis Sequence (DIALYA)

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

Rejection or Not? Interhospital Renal Meeting 10 Oct Desmond Yap & Sydney Tang Queen Mary Hospital

Transcription:

Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes G1: Ethnicity coding Ethnicity data is recorded in the clinical information systems in the individual renal centres in the format of 9S... read codes. Ethnic category Read code Old PAS Renal Assoc New PAS White 9S1.. 0 W A1 Black Caribbean 9S2.. 1 M1 Black African 9S3.. 2 N1 Black other/non-mixed origin 9S4.. 3 P1 Indian 9S6.. 4 H1 Pakistani 9S7.. 5 J1 Bangladeshi 9S8.. 6 K1 Chinese 9S9.. 7 C R1 Black British 9S41. PD Black Caribbean 9S42. Black North African 9S43. Black other African country 9S44. Black East African Asian 9S45. Black Indian sub-continent 9S46. Black other Asian 9S47. Black Black other 9S48. B PE Black other/mixed 9S5.. Other Black Black/White origin 9S51. GC Other Black Black/Asian origin 9S52. GA Other ethnic non-mixed (NMO) 9SA.. Brit. ethnic minor. spec. (NMO) 9SA1. Brit. ethnic minor. unsp. (NMO) 9SA2. Caribbean Island (NMO) 9SA3. North African Arab (NMO) 9SA4. Other African countries (NMO) 9SA5. East African Asian (NMO) 9SA6. Indian sub-continent (NMO) 9SA7. Other Asian (NMO) 9SA8. A L1 358

Coding Ethnic category Read code Old PAS Renal Assoc New PAS Irish (NMO) 9SA9. B1 Greek Cypriot (NMO) 9SAA. CG Turkish Cypriot (NMO) 9SAB. CJ Other European (NMO) 9SAC. C1 Other ethnic NEC (NMO) 9SAD. S1 Other ethnic mixed origin 9SB.. 8 Other ethnic Black/White origin 9SB1. E1 Other ethnic Asian/White origin 9SB2. F1 Other ethnic mixed white origin 9SB3. Other ethnic other mixed origin 9SB4. G1 G2: EDTA primary renal diagnoses Code Title Group 0 Chronic renal failure; aetiology uncertain unknown/unavailable Uncertain 10 Glomerulonephritis; histologically NOT examined Uncertain 11 Focal segmental glomerulosclerosis with nephrotic syndrome in children Glomerulonephritis 12 IgA nephropathy (proven by immunofluorescence, not code 76 and not 85) Glomerulonephritis 13 Dense deposit disease; membrano-proliferative GN; type II (proven by immunofluorescence Glomerulonephritis and/or electron microscopy) 14 Membranous nephropathy Glomerulonephritis 15 Membrano-proliferative GN; type I (proven by immunofluorescence and/or electron Glomerulonephritis microscopy not code 84 or 89) 16 Crescentic (extracapillary) glomerulonephritis (type I, II, III) Glomerulonephritis 17 Focal segmental glomerulosclerosis with nephrotic syndrome in adults Glomerulonephritis 19 Glomerulonephritis; histologically examined, not given above Glomerulonephritis 20 Pyelonephritis cause not specified Pyelonephritis 21 Pyelonephritis associated with neurogenic bladder Pyelonephritis 22 Pyelonephritis due to congenital obstructive uropathy with/without vesico-ureteric reflux Pyelonephritis 23 Pyelonephritis due to acquired obstructive uropathy Pyelonephritis 24 Pyelonephritis due to vesico-ureteric reflux without obstruction Pyelonephritis 25 Pyelonephritis due to urolithiasis Pyelonephritis 29 Pyelonephritis due to other cause Pyelonephritis 30 Interstitial nephritis (not pyelonephritis) due to other cause, or unspecified (not mentioned Interstitial above) 31 Nephropathy (interstitial) due to analgesic drugs Interstitial 32 Nephropathy (interstitial) due to cis-platinum Interstitial 33 Nephropathy (interstitial) due to cyclosporin A Interstitial 34 Lead induced nephropathy (interstitial) Interstitial 39 Drug induced nephropathy (interstitial) not mentioned above Interstitial 40 Cystic kidney disease type unspecified Cystic/poly 41 Polycystic kidneys; adult type (dominant) Cystic/poly 42 Polycystic kidneys; infantile (recessive) Cystic/poly 43 Medullary cystic disease; including nephronophtisis Other 49 Cystic kidney disease other specified type Other 50 Hereditary/Familial nephropathy type unspecified Other 51 Hereditary nephritis with nerve deafness (Alport s Syndrome) Other 52 Cystinosis Other 53 Primary oxalosis Other 54 Fabry s disease Other 59 Hereditary nephropathy other specified type Other 60 Renal hypoplasia (congenital) type unspecified Other 61 Oligomeganephronic hypoplasia Other 359

The UK Renal Registry The Twelfth Annual Report Code Title Group 63 Congenital renal dysplasia with or without urinary tract malformation Other 66 Syndrome of agenesis of abdominal muscles (Prune Belly) Other 70 Renal vascular disease type unspecified Renal vascular disease 71 Renal vascular disease due to malignant hypertension Renal vascular disease 72 Renal vascular disease due to hypertension Renal vascular disease 73 Renal vascular disease due to polyarteritis Renal vascular disease 74 Wegener s granulomatosis Other 75 Ischaemic renal disease/cholesterol embolism Renal vascular disease 76 Glomerulonephritis related to liver cirrhosis Other 78 Cryoglobulinemic glomerulonephritis Other 79 Renal vascular disease due to other cause (not given above and not code 84 88) Renal vascular disease 80 Type 1 diabetes with diabetic nephropathy Diabetes 81 Type 2 diabetes with diabetic nephropathy Diabetes 82 Myelomatosis/light chain deposit disease Other 83 Amyloid Other 84 Lupus erythematosus Other 85 Henoch-Schoenlein purpura Other 86 Goodpasture s Syndrome Other 87 Systemic sclerosis (scleroderma) Other 88 Haemolytic Ureaemic Syndrome (including Moschcowitz Syndrome) Other 89 Multi-system disease other (not mentioned above) Other 90 Tubular necrosis (irreversible) or cortical necrosis (different from 88) Other 91 Tuberculosis Other 92 Gout nephropathy (urate) Other 93 Nephrocalcinosis and hypercalcaemic nephropathy Other 94 Balkan nephropathy Other 95 Kidney tumour Other 96 Traumatic or surgical loss of kidney Other 98 Not known Missing 99 Other identified renal disorders Other 199 Code not sent Missing 360

Coding G3: EDTA cause of death EDTA code Cause 0 Cause of death uncertain/not determined 11 Myocardial ischaemia and infarction 12 Hyperkalaemia 13 Haemorrhagic pericarditis 14 Other causes of cardiac failure 15 Cardiac arrest/sudden death; other cause or unknown 16 Hypertensive cardiac failure 17 Hypokalaemia 18 Fluid overload/pulmonary oedema 21 Pulmonary embolus 22 Cerebro-vascular accident, other cause or unspecified 23 Gastro-intestinal haemorrhage (digestive) 24 Haemorrhage from graft site 25 Haemorrhage from vascular access or dialysis circuit 26 Haemorrhage from ruptured vascular aneurysm (not code 22 or 23) 27 Haemorrhage from surgery (not codes 23, 24, 26) 28 Other haemorrhage (not codes 23 27) 29 Mesenteric infarction 31 Pulmonary infection bacterial (not code 73) 32 Pulmonary infection (viral) 33 Pulmonary infection (fungal or protozoal; parasitic) 34 Infections elsewhere except viral hepatitis 35 Septicaemia 36 Tuberculosis (lung) 37 Tuberculosis (elsewhere) 38 Generalized viral infection 39 Peritonitis (all causes except for peritoneal dialysis) 41 Liver disease due to hepatitis B virus 42 Liver disease due to other viral hepatitis 43 Liver disease due to drug toxicity 44 Cirrhosis not viral (alcoholic or other cause) 45 Cystic liver disease 46 Liver failure cause unknown 51 Patient refused further treatment for end stage renal failure (ESRF) 52 Suicide 53 ESRF treatment ceased for any other reason 54 ESRF treatment withdrawn for medical reasons 61 Uraemia caused by graft failure 62 Pancreatitis 63 Bone marrow depression (Aplasia) 64 Cachexia 66 Malignant disease in patient treated by immunosuppressive therapy 67 Malignant disease: solid tumours except those of 66 68 Malignant disease: lymphoproliferative disorders (except 66) 69 Dementia 70 Peritonitis (sclerosing, with peritoneal dialysis) 71 Perforation of peptic ulcer 72 Perforation of colon 73 Chronic obstructive pulmonary disease 81 Accident related to ESRF treatment (not 25) 82 Accident unrelated to ESRF treatment 99 Other identified cause of death 100 Peritonitis (bacterial, with peritoneal dialysis) 101 Peritonitis (fungal, with peritoneal dialysis) 102 Peritonitis (due to other cause, with peritoneal dialysis) 361

The UK Renal Registry The Twelfth Annual Report G4: Treatment timeline modality codes RR7 (version 3.14) EDTA code TXT timeline* QUA/QBL treatment** Description 1 1 1 Haemodialysis 2 2 2 Haemofiltration 3 3 3 Haemodiafiltration 1 4 4 Haemodialysis >4 days per week/daily 4 5 5 Ultrafiltration 4 9 9 Haemodialysis type unknown 5 10 10 CAPD connect 5 11 11 CAPD disconnect 6 12 12 Cycling PD 56 nights/wk dry 6 13 13 Cycling PD <6 nights/wk dry 6 14 14 Cycling PD 56 nights/wk wet (day dwell) 6 15 15 Cycling PD <6 nights/wk wet (day dwell) 16 16 Assisted Cycling PD 56 nights/wk dry 17 17 Assisted Cycling PD 56 nights/wk wet (day dwell) 7 19 19 Peritoneal dialysis type unknown 8 20 20 Transplant; Cadaver donor 9 21 21 Transplant; Live related sibling 10 22 22 Transplant; Live related parent or child 23 23 Transplant; Live related other 11 24 24 Transplant; Live genetically unrelated 12 25 25 Transplant; Cadaver donor þ transp other organ 13 26 26 Transplant; Live donor þ transplant other organ 27 27 Transplant; Cadaver donor non-uk transplant 87 87 Transplant; Live donor non-uk transplant 8 28 28 Transplant; non-heart-beating donor 14 29 29 Transplant; type unknown 30 Graft failure 31 Graft acute rejection episode biopsy proven 32 29 Graft acute rejection episode no biopsy 35 29 Transfer in pre-emptive transplant 36 Transfer out pre-emptive transplant 37 Transfer to adult nephrology 15 38 Patient transferred out 16 39 Transfer in from another centre treatment unknown 16 41 1 Transfer in on: Haemodialysis 16 42 2 Transfer in on: Haemofiltration 16 43 3 Transfer in on: Haemodiafiltration 16 44 4 Transfer in on: Haemodialysis >4 days per week 16 45 5 Transfer in on: Ultrafiltration 16 49 9 Transfer in on: Haemodialysis type unknown 16 50 10 Transfer in on: CAPD connect 16 51 11 Transfer in on: CAPD disconnect 16 52 12 Transfer in on: Cycling PD 56 nights/wk with without bag 16 53 13 Transfer in on: Cycling PD <6 nights/wk dry 16 54 14 Transfer in on: Cycling PD 56 nights/wk wet (day dwell) 16 55 15 Transfer in on: Cycling PD <6 nights/wk wet (day dwell) 16 56 16 Transfer in on: Assisted Cycling PD 56 nights/wk dry 16 57 17 Transfer in on: Assisted Cycling PD 56 nights/wk wet (day dwell) 16 59 19 Transfer in on: Peritoneal dialysis type unknown 16 60 20 Transfer in on: Transplant; Cadaver donor 16 61 21 Transfer in on: Transplant; Live related sibling 16 62 22 Transfer in on: Transplant; Live related parent or child 16 63 23 Transfer in on: Transplant; Live related other 16 64 24 Transfer in on: Transplant; Live genetically unrelated 362

Coding EDTA code TXT timeline* QUA/QBL treatment** Description 16 65 25 Transfer in on: Transplant; Cadaver þ transp other organ 16 66 26 Transfer in on: Transplant; Live donor þ transp other organ 68 28 Transfer in on: Transplant; non-heart-beating donor 16 69 29 Transfer in on: Transplant; type unknown 72 Graft functioning 76 Nephrectomy transplant 79 Transplant pancreas (only) 80 Acute renal failure not dialysed 81 Acute haemodialysis ARF 82 Acute haemofiltration ARF 83 Acute peritoneal dialysis ARF 84 ARF recovered 85 ARF stopped dialysis (without recovery of function) 86 ARF transferred out 18 90 Patient renal function recovered 91 Patient treatment stopped (without recovery of function) 92 Treatment stopped without recovery conservative management 93 Conservative Management mutual decision not to offer RRT 94 Clinical Decision not to offer RRT conservative management 17 95 Patient lost to follow up Died * TXT timeline Registry timeline ** QUA/QBL treatment quarterly and monthly treatment blocks 363